ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer

por Kyte, J. A., Røssevold, A., Falk, R. S., Naume, B.
Publicado 2020

How I treat endocrine-dependent metastatic breast cancer

por Gombos, A., Goncalves, A., Curigliano, G., Bartsch, R., Kyte, J.A., Ignatiadis, M., Awada, A.
Publicado 2023

ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer

por Kyte, J. A., Andresen, N. K., Russnes, H. G., Fretland, S. Ø., Falk, R. S., Lingjærde, O. C., Naume, B.
Publicado 2020

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients

por Mu, L J, Kyte, J A, Kvalheim, G, Aamdal, S, Dueland, S, Hauser, M, Hammerstad, H, Waehre, H, Raabe, N, Gaudernack, G
Publicado 2005

Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment

por Aamdal, E., Skovlund, E., Jacobsen, K.D., Straume, O., Kersten, C., Herlofsen, O., Karlsen, J., Hussain, I., Amundsen, A., Dalhaug, A., Nyakas, M., Hagene, K.T., Holmsen, K., Aamdal, S., Kaasa, S., Guren, T.K., Kyte, J.A.
Publicado 2022